MetLife’s Asia segment delivered adjusted earnings of US$550 million in the third quarter of 2026, up 17% on a reported basis and 21% on a constant currency basis when notable items are excluded, the strongest quarterly earnings performance from the region in at least three quarters.
Quarterly sales came in at US$728 million, down 6% on a constant currency basis from the same period last year. Q3 2025 was an exceptional quarter for MetLife Asia. Total region sales grew 34% on a constant currency basis that period, with Japan alone up 31%, powered by new retirement-oriented product launches and a surge in foreign currency life sales. The Q3 2026 comparison is against one of the strongest base periods in the region’s recent history and not a sign of underlying demand softening.
Several factors converged to produce the Q3 earnings result. Variable investment income (VII), driven by higher private equity returns, contributed meaningfully to the increase, the same dynamic lifting MetLife’s other segments, with group-level VII reaching US$720 million pre-tax in Q3, well above the company’s US$400 million quarterly target. For the Asia segment specifically, VII gains were compounded by higher recurring investment income on fixed income securities as the region’s portfolio benefited from reinvestment at higher yields.
Volume growth was another driver, with higher fee income and positive net flows producing higher average invested assets across the region. Asia general account assets under management reached US$145 billion at amortised cost at September 30, up 4% on a constant currency basis year-over-year.
MetLife’s annual actuarial assumption review, which reduced earnings across most of its global segments in Q3, produced a $52 million favourable post-tax adjustment for Asia, the only major segment to generate a positive actuarial result from the review. That gain adds to the reported earnings figure but strips out in the ex-notables number, which is the more reliable reflection of the underlying business.
The more durable signal in the Asia numbers is the nine-month trajectory. Year-to-date sales are up 10% on a constant currency basis, led by Japan and Korea, a continuation of the momentum that has made both markets the region’s primary growth engines through 2026.
Japan’s performance has been particularly consistent. Japan sales rose 26% in Q1 2026 and Korea grew 44% in the same period, driven by new product launches and distribution strength across both agency and bancassurance channels.
Through Q3, year-to-date momentum in both markets remained positive despite the Q3 quarterly step-back. MetLife CEO Michel Khalaf has described Korea as among the company’s top five markets worldwide, and the carrier’s strategic commitment to both markets is reflected in operational decisions.
MetLife Korea relocated its headquarters in Seoul in October 2026 to consolidate operations, and MetLife Japan introduced a refreshed brand identity in April. MetLife Korea’s headquarters move is part of a broader effort to deepen internal collaboration as the company pursues its top-five ambition in one of Asia’s most competitive life insurance markets.
The announcement notes that earnings growth in Asia was “partially offset by less favorable underwriting,” a change from earlier quarters in 2026 when underwriting had been broadly supportive. The specific lines and markets involved are not broken out in the earnings release, but prior 10-Q filings have identified Japan’s foreign currency product mix and Korea’s group health lines as the most variable underwriting contributors in the region.
This warrants watching in Q4, particularly given the strong sales volumes being written into the book through 2026. Higher sales volumes can widen underwriting exposure before the in-force book matures.
MetLife reported Q3 2026 group-level adjusted earnings of US$1.8 billion, up 12%, with adjusted earnings per share excluding total notable items reaching US$2.85, the highest quarterly figure in the company’s history. Net income of US$2.4 billion was substantially inflated by a US$698 million net derivative gain tied to interest rate movements, and should be read against the adjusted figure rather than as a reflection of operating performance.
Asia’s US$145 billion general account AUM and consistent volume growth through 2026 position the region as one of MetLife’s more reliable earnings contributors heading into year-end, even as the Q3 quarterly sales comparison temporarily reversed a run of double-digit gains.
